Filing Details
- Accession Number:
- 0001225208-17-010625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-31 18:49:27
- Reporting Period:
- 2017-05-31
- Filing Date:
- 2017-05-31
- Accepted Time:
- 2017-05-31 18:49:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1308771 | B Patrick Verguet | One Edwards Way Irvine CA 92614 | Cvp, Europe | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-31 | 10,000 | $44.62 | 139,137 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-31 | 10,000 | $114.88 | 129,137 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2017-05-31 | 10,000 | $0.00 | 10,000 | $44.62 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
38,800 | 2012-05-12 | 2018-05-11 | No | 4 | M | Direct |
Footnotes
- This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- This transaction was executed in multiple trades at prices ranging from $114.7519 to $115.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.